CDSCO, State Drugs Administration Begin Joint Inspection Of Drug Manufacturing Units

The Central Drugs Standard Control Organisation (CDSCO) has started conducting joint inspection of identified Drug Manufacturing Units along with state drugs control administration as per risk based approach, an official statement said on Tuesday (27 December).

The inspection from CDSCO comes after directions of Union Health Minister Mansukh Mandaviya.

The joint inspections are being conducted all over the country as per the Standard Operating Procedures, the Health Ministry said in a statement.

An action plan for nationwide inspection of manufacturing units which are identified to be at the risk of manufacturing not of Standard Quality (NSQ)/adulterated/spurious drugs was made prior to carrying out of inspections, the ministry said.

The objective of drug regulation is to ensure safety, efficacy and quality of the drugs available in the country.

The drug control administration is required to ensure that manufacturing units comply with Drugs & Cosmetics Act, 1940 and Rules thereunder especially to the requirements of Good Manufacturing Practices (GMP), the ministry said.